
Outer Biosciences is dedicated to improving human skin health through the discovery and development of novel bioactives. Utilizing a fully-integrated technology platform, the company combines advanced ex vivo skin models with multimodal data analysis and predictive machine learning to identify effective and safe compounds for health, skincare, and cosmetic products. Founded by a team with extensive experience in engineering advanced organ systems, Outer Biosciences aims to deliver breakthrough solutions that are more effective and safer than existing options in the market.

Outer Biosciences is dedicated to improving human skin health through the discovery and development of novel bioactives. Utilizing a fully-integrated technology platform, the company combines advanced ex vivo skin models with multimodal data analysis and predictive machine learning to identify effective and safe compounds for health, skincare, and cosmetic products. Founded by a team with extensive experience in engineering advanced organ systems, Outer Biosciences aims to deliver breakthrough solutions that are more effective and safer than existing options in the market.
Founded: 2020
HQ: Palo Alto, California, United States
Focus: Discovery of bioactive compounds for skin health using ex vivo skin models + ML
Employees: ~19
Known investors: Liquid 2 Ventures; Olive Capital
| Company |
|---|
Skin health — discovery of bioactive compounds for therapeutic, skincare, and cosmetic applications.
2020
Biotechnology
$4,000,000
Dealroom lists an Apr 2022 early VC round of $4.0M.
Crunchbase lists a seed round with date listed as 2023-01-01; amount redacted in source.
“Liquid 2 Ventures; Olive Capital”